Cargando…

Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine”

Detalles Bibliográficos
Autores principales:	Schwotzer, Nora, Kissling, Sébastien, Fakhouri, Fadi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156905/ https://www.ncbi.nlm.nih.gov/pubmed/34052236 http://dx.doi.org/10.1016/j.kint.2021.05.006

Ejemplares similares

Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
por: Kervella, Delphine, et al.
Publicado: (2021)

Letter Regarding “Granulomatous Inflammation and Hypercalcemia in Patients With Severe Systemic Oxalosis”
por: Halfon, Matthieu, et al.
Publicado: (2022)

Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine
por: Salem, Fadi, et al.
Publicado: (2021)

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
por: Holzworth, Amy, et al.
Publicado: (2021)

Reply to Letter to the Editor Regarding: “Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination”
por: Holland, David J., et al.
Publicado: (2022)

Relapse of minimal change disease and inactivated SARS-CoV-2 vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

The Rational Use of Complement Inhibitors in Kidney Diseases
por: Fakhouri, Fadi, et al.
Publicado: (2022)

Passive inhaled mRNA vaccination for SARS-Cov-2
por: Yeo, Wee Song, et al.
Publicado: (2021)

The authors reply
por: Kissling, Sébastien, et al.
Publicado: (2020)

Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report
por: Özkan, Gülsüm, et al.
Publicado: (2021)

Ramsay Hunt syndrome following mRNA SARS-COV-2 vaccine()
por: Rodríguez-Martín, Minerva, et al.
Publicado: (2022)

Note for “Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination”()
por: Rodríguez-Martín, Minerva
Publicado: (2022)

Reply to Letter to Editor: Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
por: Kamel, Walaa A., et al.
Publicado: (2021)

SARS-CoV-2 mRNA vaccination, prostate cancer and steroids: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Relapsed Disciform Stromal Herpetic Keratitis and mRNA COVID-19 Vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Parsonage Turner Syndrome Following Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2022)

Small-Fiber Neuropathy After Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2023)

Relapse of class V lupus nephritis after vaccination with COVID-19 mRNA vaccine
por: Tuschen, Katharina, et al.
Publicado: (2021)

Severe rhabdomyolysis and SARS-CoV-2 vaccination: a reply to the letter by Dr. Josef Finsterer.: Reply to Letter to the Editor regarding our report to Dr. Finsterer.
por: Kamura, Yuya, et al.
Publicado: (2022)

Letter regarding: “A Case of Gross Hematuria and IgA Nephropathy Flare-Up Following SARS-CoV-2 Vaccination”
por: Park, Ken, et al.
Publicado: (2021)

Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2
por: Oniszczuk, Julie, et al.
Publicado: (2021)

Seroconversion after SARS-CoV-2 mRNA booster vaccine in cancer patients
por: Patelli, Giorgio, et al.
Publicado: (2022)

Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Delayed skin reactions and mRNA vaccines against SARS-CoV-2: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Atypical HUS relapse triggered by COVID-19
por: Ville, Simon, et al.
Publicado: (2021)

New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
por: Arismendez, Alan A., et al.
Publicado: (2023)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines [Letter]
por: Ali, Anumta, et al.
Publicado: (2023)

Letter to Editor “Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs”: Important concerns on the validity of this article
por: Barrière, Jérôme, et al.
Publicado: (2023)

Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
por: Xu, Xingli, et al.
Publicado: (2022)

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
por: Zhang, Na-Na, et al.
Publicado: (2022)

Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

Acute myopericarditis after administration of mRNA vaccines against the SARS-CoV-2 virus()
por: Gómez Martín, Alba María, et al.
Publicado: (2022)

SARS-CoV-2 mRNA Vaccination-induced Autoimmune Polyarthritis-like Rheumatoid Arthritis
por: Abe, Nobuya, et al.
Publicado: (2022)

Comment on: Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination
por: Panigrahi, Pradeep K
Publicado: (2022)

Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h83tav99ke2ebtlbhqk80ovpvq